bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · IEX Real-Time Price · USD
2.450
-0.050 (-2.00%)
At close: Jul 19, 2024, 4:00 PM
2.650
+0.200 (8.16%)
Pre-market: Jul 22, 2024, 7:19 AM EDT
bioAffinity Technologies Market Cap
bioAffinity Technologies has a market cap or net worth of $28.56 million as of July 22, 2024. Its market cap has increased by 83.08% in one year.
Market Cap
28.56M
Enterprise Value
27.60M
1-Year Change
83.08%
Ranking
Category
Stock Price
$2.45
Market Cap Chart
Since the IPO on September 1, 2022, bioAffinity Technologies's market cap has decreased from $44.99M to $28.56M, a decrease of -36.52%. That is a compound annual growth rate of -21.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 28.60M | 104.29% |
| Dec 29, 2023 | 14.00M | 4.48% |
| Dec 30, 2022 | 13.40M | -70.22% |
View and export this data all the way back to 2022.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Akari Therapeutics, | 29.66M |
| Surrozen | 29.59M |
| Daré Bioscience | 29.50M |
| Brainstorm Cell Therapeutics | 29.20M |
| Streamline Health Solutions | 29.15M |
| Enlivex Therapeutics | 28.39M |
| Bolt Biotherapeutics | 27.83M |
| Palatin Technologies | 27.59M |